Sign inJoin free

Watch / Small Cap

Steve's verdict on a 'cloudy downgrade' from THL | 4D Medical's momentum

9 May 202326:06

Steve's verdict on a 'cloudy downgrade' from THL | 4D Medical's momentum

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

There's a medical theme going on the 'small caps' latetly. We're talking to two CEOs, one in imaging software, and another in diagnostics. We had Steve Johnson from Forager Funds Management ready to spill the beans on some market insights. Steve's got his eyes on tourism holdings (THL), which took a bit of a hit today. Don't worry, though, he's still a believer in the long-term story.

Yesterday we spoke to Henry Jennings about a small cap stock he had his eye on. 4DMedical (4DX), the lung imaging software company is in the market for fresh funds, looking to raise $35 million via a share purchase plan at 91 cents per share. Today we had 4DMedical's CEO Andreas Fouras joining us to tell more about the company's performance.

And a new breast cancer blood screening tool by an Aussie Bio-tech company BCAL diagnostics (BDX) is set to change the future of early detection. BCAL is still looking for more blood samples from a wide cross section of ethnicity, age and health status, to participate in the ongoing development of its blood screening innovation. You can register your interest online at www.bcaldiagnostics.com. BCAL's executive Chair, Jayne Shaw joined us live in the studio to tell more.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy